
Oramed Pharmaceuticals Inc.
ORMP institutional ownership changes in Q2 2026: 39 institutions opened or added positions, 16 trimmed or exited. ORMP (Oramed Pharmaceuticals Inc.) is held by 55 institutional investors as of Q2 2026. Top institutional shareholders: Mercer Global Advisors Inc. ($18.3M), BlackRock, Inc. ($7.7M), Geode Capital Management, LLC ($2.4M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Oct 2, 2026 · Activists Aug 14, 2026 · Congress Feb 25, 2025
Top Holders
Showing 1-20 of 60
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about ORMP
Who owns ORMP?
55 institutional investors held ORMP on June 30, 2026, led by Mercer Global Advisors Inc. ($18.3M), BlackRock, Inc. ($7.7M) and Geode Capital Management, LLC ($2.4M).
How many hedge funds hold ORMP?
55 institutional investors reported ORMP in their 13F filings for the quarter ended June 30, 2026, $44M in all. 2 of them are rated Elite.
Are institutions buying or selling ORMP?
Buying, on balance. In Q2 2026, 39 institutions opened or added to positions in ORMP and 16 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer